Gonzales, Gina .
HRN: 20-17-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2024
MUPIROCIN 2%, 15G (TUBE)
07/05/2024
07/12/2024
TOPICAL
2% 15g
Bid
Post Op Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes